Apex Venture Advisors (AVA) is the parent firm of AVA Investment Analytics focused on the private markets.
Mike Stathis serves as the Managing Principal of Apex Venture Advisors (AVA), a business and investment intelligence firm consulting venture firms, corporations and hedge funds. AVA consists of three units: a private markets division, a public markets division and a publishing company. Mike’s work in the private markets includes valuation analysis, deal structuring, and business strategy, with a technology focus in biopharmaceuticals, healthcare IT and telemedicine.
In the public markets Mike assists hedge funds, endowments and financial firms as the Chief Investment Strategist of AVA Investment Analytics. He provides clients with proprietary investment strategies, valuation analysis, market forecasting, risk management and distressed securities analysis.
As the only investment expert who predicted the financial apocalypse in detail, as documented in the 2006 release of America’s Financial Apocalypse and the 2007 release of Cashing in on the Real Estate Bubble, Mike has been particularly active helping investors navigate the real estate and banking crisis. The accuracy of his predictions has positioned him as one of America’s most insightful and creative financial experts. His first book, The Startup Company Bible for Entrepreneurs has been used in business schools as a required text for completion of the MBA program.
Prior to Apex Advisors, Mike worked at UBS and Bear Stearns, focusing on asset management and merchant banking. He holds a Masters of Science in biological chemistry and biophysics from the University of Pennsylvania and was formerly a National Science Foundation research fellow at U.C. Berkeley.
Mike has previously provided his expertise to several corporations, hedge funds and venture capital firms. He has carved out business strategies and written business plans for Fortune 500 corporations and venture fund investments. He has provided private and public company valuation and securities analysis to fund managers, venture capital and private equity investors. He has even been consulted by hedge funds seeking to better understand the science and intellectual property challenges found in the biopharmaceuticals industry.
Mike also has an extensive science background. He taught several college level chemistry courses. While in college, he ran an examination prep business providing college students with a one-day crash course for students preparing for general chemistry, organic chemistry, biochemistry, genetics, cellular biology and immunology examinations. He also created a one-of-a-kind biotechnology course which he taught to patent attorneys and biotechnology business consultants. Mike has performed research in the oil industry, worked as a research associate in solid-state physics under a National Science Foundation fellowship. Finally, he engaged in research related to solar energy many years before solar power became commercially feasible.
For investment funds and financial institutions seeking to improve their performance